Results (3689)
EMA and HMA update principles for identification and disclosure of commercially confidential information and personal data
EMA's Executive Director shares her end-of-year message and takes stock of EMA's work in 2024
The European Medicines Agency's (EMA) office is closed from 18:00 on 19 December 2024 to 08:30 on 6 January 2025
Report outlines recommendations and next steps
Work programme and budget for 2025 among other topics
Emcitate can be used in patients of all ages
Seventeen new medicines recommended for approval; another eight medicines recommended for extension of their therapeutic indications
Oral medicine to treat two different conditions, rare von Hippel-Lindau disease and advanced clear cell renal cell carcinoma
Benefit of medicine used in Crohn’s disease no longer demonstrated
Positive opinion for extension of indication from age of six